India has taken a historic step in strengthening women’s healthcare by introducing vaccination against cervical cancer into the national immunisation framework under the Mission Indradhanush. The initiative aims to protect millions of young girls from one of the most common cancers affecting women in the country.
The nationwide campaign was launched in February 2026 and targets adolescent girls, primarily those aged around 14 years. The vaccination is being provided free of cost at government health facilities across all states and union territories. The programme is designed to significantly reduce cervical cancer cases and improve long-term public health outcomes.
Why the Cervical Cancer Vaccine Is Important
Cervical cancer remains a major health concern in India. It is currently one of the leading cancers among women, with tens of thousands of new cases reported every year. Health experts emphasize that early vaccination can dramatically reduce the risk of developing this disease later in life.
Medical research shows that the vaccine can reduce the risk of cervical cancer by more than 85% when administered during adolescence. The vaccine protects against the human papillomavirus (HPV), which is responsible for the majority of cervical cancer cases worldwide.
Key Highlights of the National Vaccination Programme
1. Nationwide Coverage
The government aims to vaccinate approximately 1.2 crore eligible girls across India during the initial phase of the campaign.
2. Free Vaccination
The vaccine is provided at no cost through public health centres, district hospitals, and medical colleges.
3. Target Age Group
The programme focuses primarily on adolescent girls, especially those around 14 years of age.
4. Voluntary Participation
Vaccination is voluntary, and parental consent is required before administration.
5. Long-Term Health Protection
The initiative forms part of a broader strategy that includes screening, early diagnosis, and treatment to reduce the burden of cervical cancer nationwide.
Role of Mission Indradhanush in Expanding Immunisation
The Mission Indradhanush was launched in 2014 to increase vaccination coverage across the country. Its primary goal is to ensure that children and vulnerable populations receive protection against preventable diseases through routine immunisation services.
With the addition of the cervical cancer vaccine, the programme has expanded its scope to include preventive healthcare measures targeting adolescent girls and women, marking a significant shift toward long-term disease prevention.
Government’s Objective and Public Health Impact
The government aims to eliminate cervical cancer as a public health problem in the coming decades. Experts believe that widespread vaccination, combined with regular screening, can significantly reduce mortality rates associated with the disease.
India’s immunisation programme is already one of the largest in the world, reaching millions of beneficiaries every year and continuously expanding to include new vaccines and health interventions.
Public health officials have described the inclusion of the cervical cancer vaccine as a milestone in preventive healthcare and a major step toward improving women’s health across the country.
Conclusion
The launch of cervical cancer vaccination under Mission Indradhanush represents a landmark development in India’s healthcare system. By providing free and accessible vaccines to adolescent girls, the government is taking proactive steps to protect future generations from a preventable disease.
This initiative not only strengthens the national immunisation programme but also demonstrates a strong commitment to improving women’s health, reducing cancer-related deaths, and building a healthier society.
